Trademarkia Logo

Canada

C$
Trademark Search in Canada
CYTUNE

View On IC.GC.CA

CYTUNE
REGISTERED

on 5 Jan 2024

Last Applicant/ Owned by

CYTUNE PHARMA S.A.S.

3 Chemin du Pressoir ChênaieF-44100 Nantes

FR

Serial Number

2094425 filed on 4th Dec 2020

Registration Number

TMA1216949 registered on 5th Jan 2024

Registration expiry Date

4th Dec 2030

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

CA

M5H2T6

CYTUNE

Trademark usage description

pharmaceuticals, medical and veterinary preparations for the prevention and treatment of neoplasia, tumors, cancer and infectious diseases; anticancer Read More

Classification Information

Class [005]
Pharmaceuticals, medical and veterinary preparations for the prevention and treatment of neoplasia, tumors, cancer and infectious diseases; anticancer preparations; antitumor drugs; Human and veterinary vaccines; anticancer vaccines for human use; Pharmaceutical preparations for the treatment of neoplasia, tumors, cancer and infectious diseases, namely, peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs for medical and veterinary purposes; biological preparations for the treatment of neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; cellular preparations for the treatment of neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; human allograft tissue; radiopharmaceutical preparations for diagnostic, medical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and infectious diseases; clinical diagnostic reagents; diagnostic agents, preparations and test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and biopsies for use in disease detection, namely, neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; drug delivery agents in the form of excipients and drug carriers that increase bioavailability and improve pharmacokinetics for a wide variety of pharmaceuticals; adjuvants for vaccines; dietetic substances consisting of vitamins, minerals, amino acids and trace elements

Classification kind code

11

Class [042]
Scientific and technological services, namely, research and design in the field of biotechnological and pharmaceutical research and development; industrial analysis and research services in the field of biotechnological and pharmaceutical research and development; scientific research and development for medical and veterinary purposes in the area of cancerous diseases, autoimmune diseases and infectious diseases; drug development services; conducting clinical trials for others; preclinical and clinical research; pharmaceutical and medical product research, development, safety testing, efficacy and quality control testing services; scientific research and development for medical diagnostic purposes; computer-aided medical diagnostic testing services; design and development of computer software and databases; design and development of computer software and databases for logistics, supply chain management and laboratory management

Classification kind code

11

Class [044]
Medical consulting services in the field of the treatment of neoplasia, tumors, cancer and infectious diseases; medical diagnostic services

Classification kind code

11

Mark Details

Serial Number

2094425

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 9th Aug 2022		Agent Changed
Submitted for opposition 22
on 21st Jul 2022		Search Recorded
Submitted for opposition 20
on 21st Jul 2022		Examiner's First Report
Submitted for opposition 223
on 21st Jul 2022		Total Provisional Refusal
Submitted for opposition 256
on 25th Jan 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 25th Mar 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 24th Mar 2021		Formalized
Submitted for opposition 1
on 24th Mar 2021		Created
Submitted for opposition 228
on 4th Dec 2020		International Registration
Submitted for opposition 30
on 4th Dec 2020		Filed